European Tourism is Rebounding Despite Rising Flight Costs

As the world returns to life before the COVID-19 pandemic brought many industries to a halt, the travel industry is one of the primary areas re-experiencing a boom.

One destination that is particularly seeing the benefits of travel again is Europe. The continent has recently seen a rise in tourism numbers nearly identical to what it was before travel restrictions. Travel expert and author Sarah Dandashy said, “European summer travel is actually returning to normal, and we’re returning to pre-pandemic levels for the first time.”

Per a study conducted by Squaremouth, Europe normally made up half of all trips booked during the summer. That number is expected to go up by one percent this summer and is predicted to be at 52 percent by the following summer. The news should be of no surprise as many predictions concluded that once European countries reopened to American tourists once again, the numbers would increase. According to Travel Agent Central, Europe will see a 600 percent increase from American travelers.

Dandashy said that countries that saw a major downturn in tourism are now seeing a sudden increase again.

“Another thing that’s also really interesting is seeing countries that are really regaining popularity. We’ve got Italy, France, the U.K., Greece, Germany — all very high on the list,” said Dandashy.

Despite the promising future the European tourism industry and its visitors can expect to enjoy, the latter will have to make more expenses.

“Also, not too much of a surprise but trips this summer are actually costing more than before,” said Dandashy.

What used to cost $6,709 will now cost $1,000 more for a whopping $7,819, per the Squaremouth study. International travel once accounted for 84 percent of all trips, and is currently not too far behind at 79 percent.

Travelers are expected to dole out more cash for their trips to Europe this summer. Prices are up globally, especially for flights, but Americans are willing to bear the extra costs for their vacations, according to USA Today.

Dandashy is optimistic about travel and as summer traveling further demonstrates the high hopes for normalcy in traveling again.

“This year we’re absolutely looking at seeing that sort of getting back to normal,” she said.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More